196 related articles for article (PubMed ID: 19557469)
1. [Systemic chemotherapy for bladder cancer: news in 2009].
Retz M; Gschwend JE; Lehmann J
Urologe A; 2009 Jun; 48(6):655-62. PubMed ID: 19557469
[TBL] [Abstract][Full Text] [Related]
2. [Update on chemotherapy for bladder cancer. Update 2010].
Heck MM; Gschwend JE; Retz M
Urologe A; 2010 Oct; 49(10):1294-300. PubMed ID: 20859610
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises.
Aragon-Ching JB; Trump DL
Future Oncol; 2016 Sep; 12(17):2049-58. PubMed ID: 27306417
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy for urothelial cancer.
Sonpavde G; Hutson TE; Berry WR
Clin Genitourin Cancer; 2006 Jun; 5(1):34-42. PubMed ID: 16859577
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
Walther PJ
Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
[No Abstract] [Full Text] [Related]
6. [Systemic chemotherapy of urothelial cancer].
Wolff JM; Jakse G
Urologe A; 1992 May; 31(3):W19-24. PubMed ID: 1615589
[No Abstract] [Full Text] [Related]
7. Second-line systemic therapy for metastatic urothelial carcinoma of the bladder.
Ortmann CA; Mazhar D
Future Oncol; 2013 Nov; 9(11):1637-51. PubMed ID: 24156324
[TBL] [Abstract][Full Text] [Related]
8. Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?
Tachibana I; Bandali E; Calaway AC; Krishnan N; Cheng L; Adra N; Kaimakliotis HZ
Urol Oncol; 2020 Nov; 38(11):850.e1-850.e7. PubMed ID: 32693973
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.
Smith MR; Kantoff PW
Semin Oncol; 1995 Dec; 22(6):625-32. PubMed ID: 8539637
[TBL] [Abstract][Full Text] [Related]
10. Management of locally advanced bladder cancer: early vs deferred chemotherapy.
Syed S; Weiss GR
World J Urol; 2002 Aug; 20(3):175-82. PubMed ID: 12196901
[TBL] [Abstract][Full Text] [Related]
11. [Systemic chemotherapy for transitional cell carcinoma of the urothelium].
Lehmann J; Retz M; Hack M; Siemer S; Stöckle M
Onkologie; 2003 Oct; 26 Suppl 4():18-25. PubMed ID: 14605452
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.
Sonpavde G; Amiel GE; Mims MP; Hayes TG; Lerner SP
Expert Opin Pharmacother; 2008 Aug; 9(11):1885-93. PubMed ID: 18627327
[TBL] [Abstract][Full Text] [Related]
13. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
Aparicio AM; Elkhouiery AB; Quinn DI
Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
[TBL] [Abstract][Full Text] [Related]
14. Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma.
Hoffman-Censits J; Wong YN
Clin Genitourin Cancer; 2015 Aug; 13(4):302-308. PubMed ID: 25987535
[TBL] [Abstract][Full Text] [Related]
15. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
Pectasides D; Pectasides M; Economopoulos T
Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for transitional cell carcinoma of the bladder: paradigms for the design of clinical trials.
Boyar M; Petrylak DP
Curr Oncol Rep; 2005 May; 7(3):207-14. PubMed ID: 15847712
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
18. Re: Updates in the management and future landscape of urothelial carcinoma.
Sarkis J; Assaf J
J Oncol Pharm Pract; 2021 Mar; 27(2):514-515. PubMed ID: 33349147
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
McCaffrey JA; Herr HW
Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
Sternberg CN; Donat SM; Bellmunt J; Millikan RE; Stadler W; De Mulder P; Sherif A; von der Maase H; Tsukamoto T; Soloway MS
Urology; 2007 Jan; 69(1 Suppl):62-79. PubMed ID: 17280909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
